Journal of Molecular Histology, Год журнала: 2024, Номер 56(1)
Опубликована: Ноя. 29, 2024
Язык: Английский
Journal of Molecular Histology, Год журнала: 2024, Номер 56(1)
Опубликована: Ноя. 29, 2024
Язык: Английский
European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177590 - 177590
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0ACS Pharmacology & Translational Science, Год журнала: 2025, Номер unknown
Опубликована: Апрель 10, 2025
Язык: Английский
Процитировано
0Discover Oncology, Год журнала: 2025, Номер 16(1)
Опубликована: Апрель 24, 2025
Lung cancer remains a leading cause of cancer-related mortality worldwide. Its progression is intricately associated with the dynamic regulation autophagy and RNA-binding proteins (RBPs), which play crucial roles in mRNA stability, alternative splicing, cellular stress responses. This review aims to systematically analyze mechanisms through RBPs contribute lung explore potential therapeutic strategies targeting these pathways. We reviewed recent studies on molecular by regulate tumor proliferation, metabolic adaptation, their interaction autophagy. The also examines dual cancer, highlighting its context-dependent effects cell survival death. interactions regulatory networks between involve multiple levels regulation. can directly influence processes act as microRNA (miRNA) sponges stability. modulation affects expression autophagy-related genes (ATGs) autophagosome formation. Additionally, participate complex non-coding RNAs (ncRNAs), including long (lncRNAs), circular (circRNAs), other proteins. proposes innovative that combine RBP-targeting approaches (e.g., small molecule inhibitors, CRISPR gene editing) modulators mTOR chloroquine) enhance treatment efficacy. Nanoparticle drug delivery systems epigenetic offer further opportunities for targeted interventions. lays theoretical foundation advancing research provides novel insights into synergistic therapies target both improve outcomes cancer.
Язык: Английский
Процитировано
0International Immunopharmacology, Год журнала: 2024, Номер 132, С. 112037 - 112037
Опубликована: Апрель 9, 2024
Язык: Английский
Процитировано
3Journal of Molecular Structure, Год журнала: 2024, Номер 1315, С. 138836 - 138836
Опубликована: Июнь 1, 2024
Язык: Английский
Процитировано
1Epigenomics, Год журнала: 2024, Номер 16(14), С. 985 - 998
Опубликована: Июль 17, 2024
Aim: This study aimed to investigate the role of LINC00513 in colorectal cancer (CRC) progression. Materials & methods: Cell proliferation was evaluated using Counting Kit-8. migration detected with transwell assay. RNA pull-down applied for verifying interactions between LINC00513, IGF2BP1 and connective tissue growth factor (CTGF). Results: CTGF levels were upregulated CRC. Knockdown significantly inhibited malignant behavior CRC cells. increased mRNA stability by binding IGF2BP1. Furthermore, overexpression or reversed inhibitory effect shRNA on Conclusion: promoted cell behaviors through IGF2BP1/CTGF.
Язык: Английский
Процитировано
1Cancer Biomarkers, Год журнала: 2024, Номер unknown, С. 1 - 17
Опубликована: Авг. 4, 2024
RNA-binding protein (RBP) plays pivotal roles in the malignant progression of cancer by regulating gene expression. In this paper, we aimed to develop RBP-based prognostic signature and identify critical hub RBPs bladder (BLCA). Firstly, a risk model based on differentially expressed RBP gens (DERBPs) between normal tumor tissues was successfully established, which can predict stromal score drug sensitivity. Then two another models miRNA-correlated or lncRNA-correlated were also RBMS3 identified as overlapping three models. Data from multiple bioinformatics databases revealed that an independent factor for overall survival (OS), associated with immunosuppressive microenvironment (TME) BLCA. Further, Single-cell RNA-Seq (scRNA-Seq) data human altas (HPA) database showed expression (both mRNA protein) up-regulated BLCA cells. Finally, shown be worse response immunotherapy. Overall, is key TME remodeling function may serve target
Язык: Английский
Процитировано
0World Journal of Gastrointestinal Oncology, Год журнала: 2024, Номер 16(11), С. 4354 - 4368
Опубликована: Окт. 25, 2024
The relevant mechanism of tumor-associated macrophages (TAMs) in the treatment colorectal cancer patients with immune checkpoint inhibitors (ICIs) is discussed, and application prospects TAMs reversing tolerance ICIs are discussed to provide a reference for related studies. As class drugs widely used clinical tumor immunotherapy, can act on regulatory molecules cells that play an inhibitory role - checkpoints kill tumors form response by activating variety system. sensitivity different types ICI varies greatly. phenotype function microenvironment closely efficacy ICIs. regulate phenotypic TAMs, also affect therapy. important resistance, making full use this target as therapeutic strategy expected improve immunotherapy prognosis cancer.
Язык: Английский
Процитировано
0Journal of Molecular Histology, Год журнала: 2024, Номер 56(1)
Опубликована: Ноя. 29, 2024
Язык: Английский
Процитировано
0